1.
Li Y, Hou J, Jiang H, Wang D, Fu W, Yuan Z, Chen Y, Zhou L. Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide-based regimens in multiple myeloma. Haematologica [Internet]. 2007Sep.1 [cited 2026Nov.11];92(9):1246-9. Available from: https://haematologica.org/article/view/4567